Xenon Pharmaceuticals Inc. Ratios

Ratios Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -21.68%36.50%41.15%-56.62%-1,348.47%-10,328.62%2,476.40%-609.43%-90.45%-427.88%-1,327.70%
EBIT Margin -22.04%35.50%39.15%-60.10%-1,376.43%-10,474.28%2,728.84%-627.02%-97.31%-428.45%-1,368.91%
EBITDA Margin -22.04%39.46%33.55%-101.12%-1,275.49%-10,474.28%2,728.84%-627.02%-97.31%-428.45%-1,368.91%
Operating Margin -22.04%35.50%39.15%-60.10%-1,376.43%-10,474.28%2,728.84%-627.02%-97.31%-428.45%-1,368.91%
Net Margin -30.06%14.01%45.89%-101.12%-1,348.47%-9,872.67%2,268.01%-586.13%-87.09%-418.11%-1,324.32%
FCF Margin 314.84%-12.71%-4.45%-119.75%-1,100.72%-9,337.94%2,527.33%-87.19%-157.81%-388.09%-1,101.57%
Efficiency
Assets Average 70.95M75.68M65.72M56.80M168.44M380.60M663.08M859.47M881.47M
Equity Average -84.12M-2.80M66.91M62.47M49.92M131.67M360.69M635.76M824.71M841.41M
Invested Capital -89.86M-78.37M72.78M61.03M63.90M42.93M107.48M171.35M550.03M721.50M927.92M754.90M
Asset Utilization Ratio 0.400.210.030.010.190.050.01
Leverage & Solvency
Interest Coverage Ratio -33.90151.75-0.00M-27.29-29.86-64.67
Debt to Equity 0.190.17
Debt Ratio 0.150.11
Equity Ratio -1.440.830.950.950.780.620.910.960.960.960.95
Times Interest Earned -33.90151.75-0.00M-27.29-29.86-64.67
Valuation
Enterprise Value -60.16M-49.28M196.04M56.93M73.63M7.18M159.27M197.78M361.42M1,059.88M1,874.02M2,375.61M1,750.00M
Market Capitalization 280.08M115.58M137.78M50.85M159.27M339.14M538.41M1,611.65M2,466.11M3,013.69M2,988.59M
Return Ratios
Return on Sales -0.22%0.37%0.41%-0.57%-13.48%-103.29%24.75%-6.09%-0.90%-4.28%-13.29%
Return on Capital Employed 0.20%-0.13%-0.40%-0.62%-0.20%-0.22%-0.20%-0.26%-0.33%
Return on Invested Capital -0.22%-0.22%-0.26%
Return on Assets 0.16%-0.12%-0.37%-0.57%-0.17%-0.21%-0.19%-0.21%-0.28%
Return on Equity -0.12%-4.17%-0.13%-0.39%-0.64%-0.22%-0.22%-0.20%-0.22%-0.29%